Search results
U.S. Supreme Court rejects Bristol Myers cancer-drug patent fight with Gilead
Reuters via Yahoo Finance Canada· 2 years agoWASHINGTON (Reuters) -The U.S. Supreme Court on Monday rebuffed a bid by Bristol Myers Squibb Co's...
15 Best Falling Stocks To Buy Now
Insider Monkey via Yahoo Finance Canada· 7 months agoIn this piece, we will take a look at the 15 best falling stocks to buy now. If you want to skip our overview of the current stock market environment and...
Why Is Editas (EDIT) Down 21% Since Last Earnings Report?
Zacks via Yahoo Finance Canada· 1 year agoA month has gone by since the last earnings report for Editas Medicine (EDIT). Shares have lost...
Editas (EDIT) Q4 Earnings Miss Estimates, Pipeline in Focus
Zacks via Yahoo Finance Canada· 1 year agoEditas (EDIT) reports a wider loss in the fourth quarter of 2022. The strategic reprioritization,...
Editas (EDIT) Q1 Earnings Top, Pipeline in Focus, Stock Up
Zacks via Yahoo Finance Canada· 1 year agoEditas Medicine (EDIT) stock climbs 12% on Friday and 7% in the pre-market hours today, after the...
11 Best Young Stocks to Buy and Hold For 20 Years
Insider Monkey via Yahoo Finance Canada· 7 months agoIn this article, we will take a look at the 11 best young stocks to buy and hold for 20 years. To skip our analysis of the recent market trends and...
10 Beaten Down Stocks Billionaires Are Crazy About
Insider Monkey via Yahoo Finance Canada· 7 months agoIn this article, we will take a look at the 10 beaten down stocks billionaires are crazy about. To skip our analysis of the recent market trends and...
Cure Ventures debuts with $350M life sciences fund
Pitchbook via Yahoo Finance Canada· 1 year agoFrom left, Cure Ventures managing partners Lou Tartaglia, Richard Lim and David Fallace (Kathy Tarantola Photography/courtesy of Cure Ventures) The formation of new life sciences-focused venture ...